Compounds > phenytoin
Page last updated: 2024-10-21

phenytoin and Dyslipidemia

phenytoin has been researched along with Dyslipidemia in 1 studies

Research Excerpts

ExcerptRelevanceReference
"After excluding patients in the monotherapy group with vascular etiology or previous cardiovascular events, in the remaining 400 patients, enzyme-inducer AEDs (EIAEDs), especially phenytoin (PHT), were associated with higher prevalence of dyslipidemia (PRa 1."3.85Prevalence of cardiovascular risk factors in people with epilepsy. ( Díez, L; Elosua, R; Gomez, A; Moreira, A; Roquer, J; Vivanco-Hidalgo, RM, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vivanco-Hidalgo, RM1
Gomez, A1
Moreira, A1
Díez, L1
Elosua, R1
Roquer, J1

Other Studies

1 other study available for phenytoin and Dyslipidemia

ArticleYear
Prevalence of cardiovascular risk factors in people with epilepsy.
    Brain and behavior, 2017, Volume: 7, Issue:2

    Topics: Adult; Aged; Anticonvulsants; Cardiovascular Diseases; Comorbidity; Dyslipidemias; Epilepsy; Female;

2017